330 related articles for article (PubMed ID: 25330136)
1. Interventions for tophi in gout.
Sriranganathan MK; Vinik O; Bombardier C; Edwards CJ
Cochrane Database Syst Rev; 2014 Oct; (10):CD010069. PubMed ID: 25330136
[TBL] [Abstract][Full Text] [Related]
2. Interventions for tophi in gout.
Sriranganathan MK; Vinik O; Pardo Pardo J; Bombardier C; Edwards CJ
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD010069. PubMed ID: 34379791
[TBL] [Abstract][Full Text] [Related]
3. Uricosuric medications for chronic gout.
Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
[TBL] [Abstract][Full Text] [Related]
4. Allopurinol for chronic gout.
Seth R; Kydd AS; Buchbinder R; Bombardier C; Edwards CJ
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD006077. PubMed ID: 25314636
[TBL] [Abstract][Full Text] [Related]
5. Colchicine for acute gout.
van Echteld I; Wechalekar MD; Schlesinger N; Buchbinder R; Aletaha D
Cochrane Database Syst Rev; 2014 Aug; (8):CD006190. PubMed ID: 25123076
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 inhibitors for acute gout.
Sivera F; Wechalekar MD; Andrés M; Buchbinder R; Carmona L
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD009993. PubMed ID: 25177840
[TBL] [Abstract][Full Text] [Related]
7. Pegloticase for chronic gout.
Anderson A; Singh JA
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008335. PubMed ID: 20238366
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs for acute gout.
van Durme CM; Wechalekar MD; Buchbinder R; Schlesinger N; van der Heijde D; Landewé RB
Cochrane Database Syst Rev; 2014 Sep; (9):CD010120. PubMed ID: 25225849
[TBL] [Abstract][Full Text] [Related]
9. Dietary supplements for chronic gout.
Andrés M; Sivera F; Falzon L; Buchbinder R; Carmona L
Cochrane Database Syst Rev; 2014 Oct; (10):CD010156. PubMed ID: 25287939
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs for acute gout.
van Durme CM; Wechalekar MD; Landewé RB; Pardo Pardo J; Cyril S; van der Heijde D; Buchbinder R
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD010120. PubMed ID: 34882311
[TBL] [Abstract][Full Text] [Related]
11. Dietary supplements for chronic gout.
Andrés M; Sivera F; Buchbinder R; Pardo Pardo J; Carmona L
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD010156. PubMed ID: 34767649
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.
Sundy JS; Baraf HS; Yood RA; Edwards NL; Gutierrez-Urena SR; Treadwell EL; Vázquez-Mellado J; White WB; Lipsky PE; Horowitz Z; Huang W; Maroli AN; Waltrip RW; Hamburger SA; Becker MA
JAMA; 2011 Aug; 306(7):711-20. PubMed ID: 21846852
[TBL] [Abstract][Full Text] [Related]
13. Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.
Baraf HS; Becker MA; Gutierrez-Urena SR; Treadwell EL; Vazquez-Mellado J; Rehrig CD; Ottery FD; Sundy JS; Yood RA
Arthritis Res Ther; 2013 Sep; 15(5):R137. PubMed ID: 24286509
[TBL] [Abstract][Full Text] [Related]
14. Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase.
Mandell BF; Yeo AE; Lipsky PE
Arthritis Res Ther; 2018 Dec; 20(1):286. PubMed ID: 30594229
[TBL] [Abstract][Full Text] [Related]
15. Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial.
Botson JK; Obermeyer K; LaMoreaux B; Zhao L; Weinblatt ME; Peterson J
Arthritis Res Ther; 2022 Dec; 24(1):281. PubMed ID: 36575505
[TBL] [Abstract][Full Text] [Related]
16. Colchicine for acute gout.
McKenzie BJ; Wechalekar MD; Johnston RV; Schlesinger N; Buchbinder R
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD006190. PubMed ID: 34438469
[TBL] [Abstract][Full Text] [Related]
17. Interventions for tophi in gout: a Cochrane systematic literature review.
Sriranganathan MK; Vinik O; Falzon L; Bombardier C; van der Heijde DM; Edwards CJ
J Rheumatol Suppl; 2014 Sep; 92():63-9. PubMed ID: 25180130
[TBL] [Abstract][Full Text] [Related]
18. Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviews.
Kydd AS; Seth R; Buchbinder R; Falzon L; Edwards CJ; van der Heijde DM; Bombardier C
J Rheumatol Suppl; 2014 Sep; 92():33-41. PubMed ID: 25180126
[TBL] [Abstract][Full Text] [Related]
19. Febuxostat for treating chronic gout.
Tayar JH; Lopez-Olivo MA; Suarez-Almazor ME
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD008653. PubMed ID: 23152264
[TBL] [Abstract][Full Text] [Related]
20. Lifestyle interventions for chronic gout.
Moi JH; Sriranganathan MK; Edwards CJ; Buchbinder R
Cochrane Database Syst Rev; 2013 May; 2013(5):CD010039. PubMed ID: 23728699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
